BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27532367)

  • 1. Patient Characteristics and Patient Behavior as Predictors of Outcome in Cognitive Therapy and Exposure Therapy for Hypochondriasis.
    Richtberg S; Jakob M; Höfling V; Weck F
    J Clin Psychol; 2017 Jun; 73(6):612-625. PubMed ID: 27532367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): A randomized controlled trial.
    Weck F; Neng JM; Richtberg S; Jakob M; Stangier U
    J Consult Clin Psychol; 2015 Aug; 83(4):665-76. PubMed ID: 25495359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial.
    Weck F; Neng JM; Schwind J; Höfling V
    J Anxiety Disord; 2015 Aug; 34():1-7. PubMed ID: 26093823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response and Remission After Cognitive and Exposure Therapy for Hypochondriasis.
    Weck F; Neng JM
    J Nerv Ment Dis; 2015 Nov; 203(11):883-5. PubMed ID: 26513512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Free Symptom Attributions in Hypochondriasis after Cognitive Therapy and Exposure Therapy.
    Schwind J; Neng JM; Weck F
    Behav Cogn Psychother; 2016 Sep; 44(5):601-14. PubMed ID: 27126076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive therapy and exposure therapy for hypochondriasis (health anxiety): A 3-year naturalistic follow-up.
    Weck F; Nagel LC; Höfling V; Neng JMB
    J Consult Clin Psychol; 2017 Oct; 85(10):1012-1017. PubMed ID: 28956951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety as a predictor of improvements in somatic symptoms and health anxiety associated with cognitive-behavioral intervention in hypochondriasis.
    Nakao M; Shinozaki Y; Ahern DK; Barsky AJ
    Psychother Psychosom; 2011; 80(3):151-8. PubMed ID: 21372623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of cognitive-behavioral group therapy for patients with hypochondriasis (health anxiety).
    Weck F; Gropalis M; Hiller W; Bleichhardt G
    J Anxiety Disord; 2015 Mar; 30():1-7. PubMed ID: 25589453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in negative implicit evaluations in patients of hypochondriasis after treatment with cognitive therapy or exposure therapy.
    Schreiber F; Witthöft M; Neng JM; Weck F
    J Behav Ther Exp Psychiatry; 2016 Mar; 50():139-46. PubMed ID: 26204567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of course and outcome in hypochondriasis after cognitive-behavioral treatment.
    Hiller W; Leibbrand R; Rief W; Fichter MM
    Psychother Psychosom; 2002; 71(6):318-25. PubMed ID: 12411766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapist competence and therapeutic alliance are important in the treatment of health anxiety (hypochondriasis).
    Weck F; Richtberg S; Jakob M; Neng JM; Höfling V
    Psychiatry Res; 2015 Jul; 228(1):53-8. PubMed ID: 25977073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial.
    Barsky AJ; Ahern DK
    JAMA; 2004 Mar; 291(12):1464-70. PubMed ID: 15039413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of hypochondriacal patients with chronic low-back pain to cognitive-behavioral therapy.
    Nakao M; Shinozaki Y; Nolido N; Ahern DK; Barsky AJ
    Psychosomatics; 2012; 53(2):139-47. PubMed ID: 22424162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypochondriasis. Medical management and psychiatric treatment.
    Barsky AJ
    Psychosomatics; 1996; 37(1):48-56. PubMed ID: 8600495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community-based psychoeducational group approach to hypochondriasis.
    Bouman TK
    Psychother Psychosom; 2002; 71(6):326-32. PubMed ID: 12411767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochondriasis, somatoform disorders, and anxiety disorders: sociodemographic variables, general psychopathology, and naturalistic treatment effects.
    Gropalis M; Bleichhardt G; Witthöft M; Hiller W
    J Nerv Ment Dis; 2012 May; 200(5):406-12. PubMed ID: 22551794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypochondriasis and somatization.
    Kellner R
    JAMA; 1987 Nov; 258(19):2718-22. PubMed ID: 3312664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health anxiety and hypochondriasis: Description and treatment issues highlighted through a case illustration.
    Hart J; Björgvinsson T
    Bull Menninger Clin; 2010; 74(2):122-40. PubMed ID: 20545492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attribution of somatic symptoms in hypochondriasis.
    Neng JM; Weck F
    Clin Psychol Psychother; 2015; 22(2):116-24. PubMed ID: 24123559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the effect of psychoeducational group treatment for hypochondriasis.
    Buwalda FM; Bouman TK
    Clin Psychol Psychother; 2008; 15(6):396-403. PubMed ID: 19115458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.